Axsome Therapeutics | 4:持股变动声明-高管 Jacobson Mark L.
Axsome Therapeutics | 4:持股变动声明-董事 JEFFS ROGER
Axsome Therapeutics | 4:持股变动声明-董事 JEFFS ROGER
Axsome Therapeutics | 4:持股变动声明-董事 Saad Mark E
Axsome Therapeutics | 4:持股变动声明-高管 Jacobson Mark L.
Axsome Therapeutics | 4:持股变动声明-高管 Pizzie Nick
Axsome Therapeutics | 4:持股变动声明-高管 TABUTEAU HERRIOT
Axsome Therapeutics | 4:持股变动声明-董事 Mahony Susan
Axsome Therapeutics | 4:持股变动声明-高管 Murdock Hunter R.
Axsome Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(4.9%),Peter Harwin(4.9%)等
Axsome Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(9.5%),Roderick Wong, M.D.(9.5%)
Axsome Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.81%)
Axsome Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(6.8%)
Axsome Therapeutics | 4:持股变动声明-董事 Mahony Susan
Axsome Therapeutics | 3:首次持股声明-董事 Mahony Susan
Axsome Therapeutics | 4:持股变动声明-董事 Coleman Mark
Axsome Therapeutics | SC 13G:超过5%持股股东披露文件-Fairmount Funds Management LLC(5.0%),Peter Harwin(5.0%)等
Axsome Therapeutics | 4:持股变动声明-董事 Saad Mark E
Axsome Therapeutics | 4:持股变动声明-董事 JEFFS ROGER
Axsome Therapeutics | 4:持股变动声明-董事 Coleman Mark
暂无数据